Dietary supplements that boost brain power lack strong evidence Original paper
More structured and standardized studies and practices are needed to reduce inconsistencies and improve precision (e.g., dose, duration, methods, outcomes) in evaluation of the cognitive performance benefits of dietary supplements.
This Study Summary was published on October 3, 2021.
Background
“Smart drugs” or “nootropics” are essentially dietary supplements that are promoted for brain health and cognitive function. This massive market claims that these supplements benefit cognition in elderly and healthy populations by both preventing decline and boosting performance. Are the claims scientifically sound?
The study
This systematic review identified 9 (out of 54 searched) dietary supplement ingredients with at least 3 published studies (yielding a total of 69 studies) that evaluated cognitive performance benefits.
Bacopa monnieri (7 studies), choline (5 studies), creatine (3 studies), omega−3 fatty acids (10 studies), Ginkgo biloba (16 studies), ginseng (16 studies), Rhodiola rosea (5 studies), tyrosine (4 studies), and valerian root (3 studies) were compared to a placebo at various doses and durations.
The results
Overall, the studies were inconsistent and imprecise with respect to standardization of dietary supplement ingredients, dosage, and duration of use and suffered from various methodological flaws (e.g., small sample sizes, self-reported outcomes). Only 23% of the studies mentioned qualitative/quantitative purity testing of the product’s claimed bioactive ingredients.
Future studies should focus on product standardization, quality, and safety along with more consistent practices for evaluation of cognitive performance benefits.
Get free weekly updates on what’s new at Examine.
This Study Summary was published on October 3, 2021.